What is PATH?
Founded in 1977 and headquartered in Seattle, Washington, PATH operates as a nonprofit entity focused on empowering innovators to advance health equity. The organization's mission is to ensure that all individuals and communities have the opportunity to flourish. PATH's work spans various health challenges, leveraging its extensive experience to drive impactful solutions and foster a healthier world. The company's long-standing presence and commitment highlight its deep-rooted dedication to global health advancement.
How much funding has PATH raised?
PATH has raised a total of $100.2M across 6 funding rounds:
Angel/Seed
$2.5M
Series A
$10.8M
Series B
$30M
Series C
$24.9M
Unspecified
$7M
Other Financing Round
$25M
Angel/Seed (2010): $2.5M with participation from Index Ventures, Founders Fund, SV Angel, and First Round Capital
Series A (2011): $10.8M led by Digital Garage, First Round Capital, Kleiner Perkins Caufield & Byers, and Index Ventures
Series B (2012): $30M supported by Redpoint Ventures, Greylock Partners, Allen & Company, Kleiner Perkins Caufield & Byers, Index Ventures, and Shasta Ventures
Series C (2013): $24.9M featuring Greylock Partners, First Round Capital, Kleiner Perkins Caufield & Byers, Index Ventures, Redpoint Venture Partners, Bakrie & Brothers, and Insight Venture Partners
Unspecified (2013): $7M, investors not publicly disclosed
Other Financing Round (2017): $25M with participation from Clarus Ventures
Key Investors in PATH
Clarus Ventures
Blackstone Life Sciences focuses on bringing vital medicines and technologies to market, aiming to improve patient outcomes through collaboration with pharmaceutical, biotech, and medical technology companies. The firm addresses the funding gap in the life sciences sector by investing in late-stage development of innovative products.
Greylock Partners
83North is a global venture capital firm managing over $2.2 billion, investing in exceptional entrepreneurs at all stages to build category-leading companies. The firm has a strong portfolio with 90 companies and 15 unicorns, reflecting its successful investment strategy.
Kleiner Perkins Caufield & Byers
Kleiner Perkins is a Menlo Parkbased venture capital firm that raises dedicated funds and invests in early and growthstage technology and lifescience companies, backing founders across consumer, enterprise, healthcare, and climate/hard tech with capital and operational support from seed through IPO or acquisition.
What's next for PATH?
With a substantial history of financial backing, including its most recent strategic investment, PATH is well-positioned to expand its influence and impact in the global health sector. The consistent flow of capital, from its early seed rounds to major enterprise-level financing, indicates strong investor confidence in PATH's mission and operational effectiveness. This sustained support will likely fuel further development of innovative health solutions, enabling the organization to address pressing health disparities and drive meaningful change worldwide. The strategic nature of recent funding suggests a focus on scaling existing programs and potentially exploring new, high-impact areas within health equity.
See full PATH company page
